Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enhabit provides Medicare-certified home health and hospice services across the United States. The company delivers skilled nursing, physical/occupational/speech therapy, medical social work, and end-of-life hospice care through an interdisciplinary team. It leverages predictive analytics and evidence-based practices to improve patient outcomes[1][6].
As of Q1 2025, it operates over 255 home health agencies and more than 110 hospice agencies in the U.S., with annual revenues exceeding $1 billion[6]. Clinical results focus on quality of life improvements for patients at home rather than traditional clinical trial endpoints.
The company was spun off from Encompass Health in July 2022 to become an independent public entity[3][5].
Recognized as one of Fortune’s Best Workplaces in Health Care multiple years running[4].
No pharmaceutical pipeline; all programs are service lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enhabit.